These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12466357)

  • 41. Lack of relationship between 11beta-hydroxysteroid dehydrogenase setpoint and insulin sensitivity in the basal state and after 24h of insulin infusion in healthy subjects and type 2 diabetic patients.
    Kerstens MN; Riemens SC; Sluiter WJ; Pratt JJ; Wolthers BG; Dullaart RP
    Clin Endocrinol (Oxf); 2000 Apr; 52(4):403-11. PubMed ID: 10762282
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity.
    Wake DJ; Rask E; Livingstone DE; Söderberg S; Olsson T; Walker BR
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3983-8. PubMed ID: 12915696
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adrenal incidentaloma: a new cause of the metabolic syndrome?
    Terzolo M; Pia A; Alì A; Osella G; Reimondo G; Bovio S; Daffara F; Procopio M; Paccotti P; Borretta G; Angeli A
    J Clin Endocrinol Metab; 2002 Mar; 87(3):998-1003. PubMed ID: 11889151
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HIS-388, a novel orally active and long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 diabetic murine models.
    Okazaki S; Takahashi T; Iwamura T; Nakaki J; Sekiya Y; Yagi M; Kumagai H; Sato M; Sakami S; Nitta A; Kawai K; Kainoh M
    J Pharmacol Exp Ther; 2014 Oct; 351(1):181-9. PubMed ID: 25100752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression and activity of 11beta-hydroxysteroid dehydrogenase type 1 enzyme in subcutaneous and visceral adipose tissue of prepubertal children.
    Mericq V; Medina P; Bouwman C; Johnson MC; Godoy J; López T; Iñiguez G
    Horm Res; 2009; 71(2):89-93. PubMed ID: 19129713
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship of non-alcoholic hepatic steatosis to cortisol secretion in diet-controlled Type 2 diabetic patients.
    Targher G; Bertolini L; Zoppini G; Zenari L; Falezza G
    Diabet Med; 2005 Sep; 22(9):1146-50. PubMed ID: 16108840
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors responsible for deteriorating glucose tolerance in newly diagnosed type 2 diabetes in Japanese men.
    Mitsui R; Fukushima M; Nishi Y; Ueda N; Suzuki H; Taniguchi A; Nakai Y; Kawakita T; Kurose T; Yamada Y; Inagaki N; Seino Y
    Metabolism; 2006 Jan; 55(1):53-8. PubMed ID: 16324919
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Absence of Cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion.
    Tomlinson JW; Draper N; Mackie J; Johnson AP; Holder G; Wood P; Stewart PM
    J Clin Endocrinol Metab; 2002 Jan; 87(1):57-62. PubMed ID: 11788623
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differentiation of adipose stromal cells: the roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase.
    Bujalska IJ; Kumar S; Hewison M; Stewart PM
    Endocrinology; 1999 Jul; 140(7):3188-96. PubMed ID: 10385414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity.
    Tomlinson JW; Sinha B; Bujalska I; Hewison M; Stewart PM
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5630-5. PubMed ID: 12466364
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
    Robaczyk MG
    Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glucocorticoid exposure and tissue gene expression of 11beta HSD-1, 11beta HSD-2, and glucocorticoid receptor in a porcine model of differential fetal growth.
    McNeil CJ; Nwagwu MO; Finch AM; Page KR; Thain A; McArdle HJ; Ashworth CJ
    Reproduction; 2007 Mar; 133(3):653-61. PubMed ID: 17379659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
    Svendsen PF; Madsbad S; Nilas L; Paulsen SK; Pedersen SB
    Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease.
    Walker BR; Andrew R
    Ann N Y Acad Sci; 2006 Nov; 1083():165-84. PubMed ID: 17148739
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Is 11beta-hydroxysteroid dehydrogenase type 1 a therapeutic target? Effects of carbenoxolone in lean and obese Zucker rats.
    Livingstone DE; Walker BR
    J Pharmacol Exp Ther; 2003 Apr; 305(1):167-72. PubMed ID: 12649365
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatic 11β-hydroxysteroid dehydrogenase type 1 activity in obesity and type 2 diabetes using a novel triple tracer cortisol technique.
    Dube S; Norby B; Pattan V; Lingineni RK; Singh RJ; Carter RE; Basu A; Basu R
    Diabetologia; 2014 Jul; 57(7):1446-55. PubMed ID: 24771091
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Abnormal glucocorticoid activity in subjects with risk factors for cardiovascular disease.
    Walker BR
    Endocr Res; 1996 Nov; 22(4):701-8. PubMed ID: 8969930
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glucocorticoid metabolism and adrenocortical reactivity to ACTH in myotonic dystrophy.
    Johansson A ; Andrew R; Forsberg H; Cederquist K; Walker BR; Olsson T
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4276-83. PubMed ID: 11549662
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alteration in glucocorticoids secretion and metabolism in patients affected by cystic fibrosis.
    Podgórski R; Sumińska M; Rachel M; Fichna M; Fichna P; Mazur A
    Front Endocrinol (Lausanne); 2022; 13():1074209. PubMed ID: 36568105
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute intrarenal administration of cortisol has no effect on renal blood flow in hypertensive individuals.
    van Uum SH; Houben AJ; Hermus AR; Kroon AA; Walker BR; Sweep CG; Smits P; de Leeuw PW; Lenders JW
    J Hypertens; 2002 Nov; 20(11):2275-83. PubMed ID: 12409967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.